Medicare reimbursement for intra-spinal therapeutics administered in the physician office setting was recently greatly reduced by CMS’ regional MACs.
This reimbursement reduction for “J3010,” hydromorphone, may make it difficult for many physicians’ pain practices to continue to provide this pharmaceutical to their patients in this convenient, comfortable, and cost-effective office setting.
Sharing your experience will help illustrate [...]